JavaScript Required

Jumpseat Aerospace News requires JavaScript to function. Please enable JavaScript in your browser settings to continue.

Varda Hits $1.6B Valuation, Expands Microgravity Manufacturing

October 1, 2026

1 min read

Key Takeaways

Varda Space Industries raises $251M in Series D funding.
Company valuation reaches $1.6B.
Two Varda capsules to launch on SpaceX's Transporter-18.
SpaceX targets three launches on October 1.

Silver membership required Upgrade to Silver to access Key Takeaways.

Upgrade

Strategic Implications

Varda's funding may indicate growing interest in microgravity manufacturing, which could signal a shift in the space industry towards more specialized production capabilities. This investment suggests a potential expansion of space-based pharmaceuticals and hypersonic reentry testbeds, which may have significant implications for the defense sector.

Silver membership required Upgrade to Silver to access Strategic Implications.

Upgrade

What Happened

Space Industry Sees Significant Investment In Microgravity Pharmaceuticals

Varda Space Industries has closed a $251M Series D funding round, pushing its valuation to $1.6B. The company, which manufactures pharmaceuticals in microgravity and provides hypersonic reentry testbeds for defense customers, has two capsules set to launch on SpaceX’s Transporter-18. SpaceX is also targeting three launches on October 1, including Crew-13 and a classified Falcon Heavy NRO mission. This development was reported by KeepTrack.

Source | Originally Published: October 1, 2026

Companies Mentioned